SenoRx, a developer of medical devices for the diagnosis and treatment of breast cancer, priced 5.5 million shares at $8, a -33% discount to the midpoint of the original $11-$13 range. The company is hoping to gain share in the fragmented $1 billion breast...read more
SenoRx, producer of medical devices for the diagnosis and treatment of breast cancer, lowered the range of its IPO Wednesday. The company will offer their shares at an anticipated price range of $9.00 to $10.00, 21% below the midpoint of the originally...read more
SenoRx, developer and manufacturer of minimally-invasive medical devices for breast cancer diagnosis, announced the terms for its IPO Wednesday. The company plans to offer 5,500,000 shares at a range of $11.00 to $13.00. Banc of America Securities and Citigroup ...read more
SenoRx, a medical device maker offering an FDA approved biopsy system to detect breast cancer, filed an S-1 registration statement with the SEC on Thursday. The California based company generated $20 million in sales over the last 12 months, but has yet to turn ...read more
Medical device maker SenoRx prices at $8
SenoRx, a developer of medical devices for the diagnosis and treatment of breast cancer, priced 5.5 million shares at $8, a -33% discount to the midpoint of the original $11-$13 range. The company is hoping to gain share in the fragmented $1 billion breast...read more
Medical device maker SenoRx lowers price range
SenoRx, producer of medical devices for the diagnosis and treatment of breast cancer, lowered the range of its IPO Wednesday. The company will offer their shares at an anticipated price range of $9.00 to $10.00, 21% below the midpoint of the originally...read more
Medical device maker SenoRx announces terms
SenoRx, developer and manufacturer of minimally-invasive medical devices for breast cancer diagnosis, announced the terms for its IPO Wednesday. The company plans to offer 5,500,000 shares at a range of $11.00 to $13.00. Banc of America Securities and Citigroup ...read more
Medical device maker SenoRx files to go public
SenoRx, a medical device maker offering an FDA approved biopsy system to detect breast cancer, filed an S-1 registration statement with the SEC on Thursday. The California based company generated $20 million in sales over the last 12 months, but has yet to turn ...read more